CTIS2023-503765-37-00进行中（未招募）1 期
An Extension Study Assessing the Long-term Safety and Efficacy of Etranacogene Dezaparvovec (CSL222) Previously Administered to Adult Male Subjects with Hemophilia B - CSL222_3003
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 56
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- Male
入选标准
- •Treatment with CSL222 in Study CSL222_2001 or Study CSL222_3001., Provided written informed consent., Willing and able to adhere to all protocol requirements.
排除标准
- •There are no exclusion criteria in this study
研究者
相似试验
进行中（未招募）
1 期
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated PaiModerate to Severe Endometriosis Associated PainMedDRA version: 16.1Level: LLTClassification code 10014788Term: Endometriosis related painSystem Organ Class: 100000004872EUCTR2013-001047-31-ITAbbVie Deutschland GmbH & Co. KG495
进行中（未招募）
1 期
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated PaiModerate to Severe Endometriosis Associated PainMedDRA version: 19.0Level: LLTClassification code 10014788Term: Endometriosis related painSystem Organ Class: 100000004872EUCTR2013-001047-31-HUAbbVie Deutschland GmbH & Co. KG523
进行中（未招募）
1 期
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated PaiModerate to Severe Endometriosis Associated PainMedDRA version: 20.0Level: LLTClassification code 10014788Term: Endometriosis related painSystem Organ Class: 100000024185EUCTR2013-001047-31-ATAbbVie Deutschland GmbH & Co. KG523
进行中（未招募）
1 期
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated PaiModerate to Severe Endometriosis Associated PainMedDRA version: 17.0Level: LLTClassification code 10014788Term: Endometriosis related painSystem Organ Class: 100000004872EUCTR2013-001047-31-ESAbbVie Deutschland GmbH & Co. KG523
进行中（未招募）
1 期
Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated PaiModerate to Severe Endometriosis Associated PainMedDRA version: 20.0 Level: LLT Classification code 10014788 Term: Endometriosis related pain System Organ Class: 100000024185EUCTR2013-001047-31-GBAbbVie Deutschland GmbH & Co. KG495